Results     10-May-17
Announcements
Astrazeneca Pharma India reports standalone net loss of Rs 2.88 crore in the March 2017 quarter
Sales decline 16.90% to Rs 110.95 crore
Net loss of Astrazeneca Pharma India reported to Rs 2.88 crore in the quarter ended March 2017 as against net profit of Rs 0.56 crore during the previous quarter ended March 2016. Sales declined 16.90% to Rs 110.95 crore in the quarter ended March 2017 as against Rs 133.51 crore during the previous quarter ended March 2016.

For the full year,net profit rose 364.64% to Rs 24.44 crore in the year ended March 2017 as against Rs 5.26 crore during the previous year ended March 2016. Sales declined 0.03% to Rs 526.31 crore in the year ended March 2017 as against Rs 526.46 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Ended
 Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.
Sales110.95133.51 -17 526.31526.46 0
OPM %-4.282.40 -5.583.12 -
PBDT1.685.30 -68 49.0323.19 111
PBT-2.001.06 PL 33.205.76 476
NP-2.880.56 PL 24.445.26 365

Previous News
  Astrazeneca Pharma India standalone net profit rises 2.57% in the March 2022 quarter
 ( Results - Announcements 27-May-22   08:06 )
  Astrazeneca Pharma gets nod from CDSCO to import Olaparib film coated tablets
 ( Hot Pursuit - 22-Nov-23   11:07 )
  Astrazeneca Pharma India standalone net profit declines 8.22% in the December 2019 quarter
 ( Results - Announcements 04-Feb-20   11:09 )
  AstraZeneca Pharma India to launch Calquence® in India
 ( Corporate News - 15-Oct-20   16:46 )
  Astrazeneca Pharma India to announce Quarterly Result
 ( Corporate News - 24-Oct-20   10:03 )
  Astrazeneca Pharma India fixes record date for interim dividend
 ( Market Beat - Reports 08-Aug-19   10:11 )
  AstraZeneca Pharma receives DCGI approval for launch of Benralizumab (Fasenra™) in India
 ( Corporate News - 21-Dec-20   08:55 )
  AstraZeneca set to launch Osimertinib 40mg/80mg film coated tablets
 ( Corporate News - 10-Mar-21   16:33 )
  Astrazeneca Pharma India reports standalone net profit of Rs 3.22 crore in the March 2018 quarter
 ( Results - Announcements 22-May-18   16:24 )
  AstraZeneca hits 52-week high on DCGI nod for Dapagliflozin tablets
 ( Hot Pursuit - 25-Jul-23   15:00 )
  AstraZeneca gains after getting approval for diabetes drug
 ( Hot Pursuit - 18-Oct-17   11:08 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top